Tag: retatrutide

Pharmaceutical research laboratory with obesity drug development
Clinical UpdatesPractice

Eli Lilly Reports Safety Data for Next-Generation Obesity Drug Retatrutide

Eli Lilly presented new safety data for retatrutide, its triple-hormone obesity drug, at the 2026 American Diabetes Association meeting. The…

By
GMJ Practice Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network